Q1 2024: What's new in Selector

We are excited to announce new enhancements in the platform between January and March 2024

Over the past three months, we’ve added data from over 2.1M publications, 17M experimental use cases, and 173K reagents model systems. Other notable updates include:

  • Added 2 million closed-access publications
  • Simplified searching by species/organism in Selector

1. Added 2 million closed-access publications

We enhanced coverage of closed-access publications and expanded our publication partnership with Springer Nature to include more publications from hundreds of journals including Nature and Nature Medicine. This increases data coverage in multiple therapeutic areas including Cardiometabolic, Neurodegeneration, Immunology and Inflammation, Infectious Diseases, Oncology, and more.

Click here to learn more about closed-access publisher partnerships.


2. Simplified searching by species/organism in Selector

We’ve restructured our species/organism data to simplify search and organization of reagent and model system data. The organism filter enables you to specify the species/organism of interest from both experiments AND vendor-provided details. Click Filter by Organism Reference to specify the data source (i.e. vendor-provided or detected in the literature) to find the most relevant information. 

Available for the following app(s): Selector. Click here to learn more.


3. Surface more data from microbial research

In the past few months, we have added over 17K experiments where reagents have been used to study particular viruses or bacteria, such as various spike proteins, glycoproteins, or lipopolysaccharides. These improvements will continue to expand our coverage of microbial-related reagent data to support and enhance a scientist’s ability to search for and surface microbial data from experimental literature.

Available for the following app(s): Selector. Click here to see more microbial data enhancements from last year.

Please note that access to these features and enhancements depends on what is available at your organization.